Academic Sessions 2022

Induction of the President and Inauguration of ClinPharm22 Academic Sessions

ClinPharm 22, Academic Session

ClinPharm 22 Conference Proceedings

Conference ProceedingsDownload

Call for Abstracts

The Sri Lanka Association of Clinical Pharmacology and Therapeutics invites you to submit abstracts for SLACPT Annual Academic Sessions to be held on the 27th of June 2022.

The deadline to submit abstracts is the 15th of May 2022, 12 midnight, Sri Lankan Time.

  • All abstract submissions should be submitted online through the abstract submission google form.
  • Please note that hard copies will NOT be accepted.
  • Corresponding / Presenting authors of abstracts should be members of the SLACPT when eligible for membership.
  • All research studies should have obtained Ethics approval. All Clinical Trials should have been registered with a Clinical Trials Registry.
  • All the authors should declare any conflicts of interest during their presentation at the congress.
  • The SLACPT reserves the right to make alterations and to edit the contents of the abstract to improve the quality of presentation and to ensure conformity with the general style of the SLACPT abstracts.

Instructions for online abstract submission

Online through the abstract submission google form. https://forms.gle/E1v7p8t2zvDKfCQr9

  1. Submitting an abstract
    1. Enter the information requested in the system. (Title, names, affiliations, presenting author, abstract text, etc.)
    2. You should receive a confirmatory email, if not please contact the SLACPT office.

(Phone number: 011-2961139, Email: slacptsessions2022@gmail.com)

Guidelines

  • The title of the paper should be concise and the SLACPT reserves the right to modify the title if necessary.
  • State whether the paper is a “Research” or “Clinical audit”
  • The author(s) name(s) should be in the format of last name/surname followed by the initial(s). Please DO NOT use prefixes such as Mr./Dr/Prof. (E.g., Smith AB)
  • Please DO NOT include the title, names of the authors, institutions, sub-headings or any tables/graphs/figures or references within the body of the abstract. Only the text of the abstract should be included.
  • The abstract must be structured as follows:
  • Introduction and objectives
  • Methods
  • Results
  • Conclusions
  • The body of the abstract MUST NOT exceed 250 words.
  • Please format the abstract as below.
    • Title: BOLD CAPITAL LETTERS
    • Authors: Last name followed by initials, with the presenting author underlined. A superscript number should be placed after each name to refer to the respective affiliations. (e.g.:- Smith AB¹, Silva CD²)
    • Affiliations: must be listed below the authors
    • Body of the abstract: Structured with subheadings: Introduction and Objectives, Method, Results, and Conclusions.
    • Font: Times New Roman
    • Font size: 12
    • Spacing: single line spacing
    • The language of the submission should be set to English (UK)

Important notices

  • Modifications to the abstract can be made until submission. Please note that NO amendments to the submitted abstracts (including the author list) would be entertained after the closing of submissions.
  • Abstracts not conforming to the above instructions will be rejected.
  • Accepted abstracts will be published in the Abstract book containing the abstracts.
  • The SLACPT  reserves the right to make alterations and to edit the title and/or the text to improve the quality.
  • A panel of reviewers will review abstracts anonymously and the decision of the Scientific Committee will be final. Successful applicants will be notified via email.
  • The presenting author of the selected papers must register before the paper is finally accepted for presentation.
  • Please provide a name of a stand-in presenting author (in case of a situation where the original presenting author is unable to attend).
  • Failure to make a presentation (oral or poster) once participation is confirmed will be considered an episode of academic/scientific misconduct and the authors will be liable for punitive action.
  • The author/s should take full public responsibility for the research work and the contents reported in the abstract.
  • If the work has been previously presented or published, in whole or in part, this should be stated clearly in the cage provided in the web portal or form. This does not disqualify a paper but must be stated when submitting the paper.